April 4, 2016 / 12:57 PM / a year ago

BUZZ-Progenics Pharmaceuticals Inc: FDA defers decision on drug

** Drug developer’s shares down 11.6 pct at $3.90 premarket

** FDA extends decision date for Progenics’ drug oral Relistor, a treatment for opioid-induced constipation, to July 19 from April 16

** Progenics co-developing drug with Valeant Pharmaceuticals International Inc

** FDA says three-month extension needed to review additional data

** Up to Friday’s close, stock had fallen 28 pct this year

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below